Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Sell
713
-109
-13% -$72.5K 0.15% 59
2026
Q1
$448K Sell
822
-921
-53% -$376K 0.15% 62
2025
Q4
$546K Buy
1,743
+218
+14% +$69.2K 0.19% 47
2025
Q3
$412K Buy
1,525
+755
+98% +$173K 0.15% 72
2025
Q2
$170K Buy
+770
New +$139K 0.07% 101

Other funds holding AGX

Kings Path Partners's AGX Position: Q2 2026 in Review

Kings Path Partners reduced its Argan (AGX) stake by 13% in Q2 2026, selling an estimated $72.5K and leaving 713 shares worth $569K. The position accounts for 0.15% of the portfolio, ranked #59.

Kings Path Partners first reported a position in AGX in Q2 2025 and has held it in 5 quarters since. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Kings Path Partners held 713 shares of Argan worth $569K as of Q2 2026.
  • Kings Path Partners sold 109 Argan shares in Q2 2026, an estimated $72.5K.
  • Argan made up 0.15% of Kings Path Partners's portfolio in Q2 2026, its #59 holding.
  • Kings Path Partners first reported a position in Argan in Q2 2025 and has held it in 5 quarters since.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.